Omega Therapeutics Financials
| OMGA Stock | USD 0.80 0.06 6.98% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.19 | 3.3531 |
|
|
The essential information of the day-to-day investment outlook for Omega Therapeutics includes many different criteria found on its balance sheet. An individual investor should monitor Omega Therapeutics' cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Omega Therapeutics.
Net Income |
|
Omega | Select Account or Indicator |
Understanding current and past Omega Therapeutics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Omega Therapeutics' financial statements are interrelated, with each one affecting the others. For example, an increase in Omega Therapeutics' assets may result in an increase in income on the income statement.
Please note, the presentation of Omega Therapeutics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Omega Therapeutics' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Omega Therapeutics' management manipulating its earnings.
Omega Therapeutics Stock Summary
Omega Therapeutics competes with Pmv Pharmaceuticals, Eliem Therapeutics, MediciNova, Pharvaris, and PepGen. Omega Therapeutics, Inc. operates as a clinical-stage biotechnology company. The company was incorporated in 2016 and is headquartered in Cambridge, Massachusetts. Omega Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 79 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US68217N1054 |
| CUSIP | 68217N105 |
| Location | Massachusetts; U.S.A |
| Business Address | 20 Acorn Park |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | omegatherapeutics.com |
| Phone | 617 949 4360 |
| Currency | USD - US Dollar |
Omega Therapeutics Key Financial Ratios
| Return On Equity | -1.29 | ||||
| Operating Margin | (7.77) % | ||||
| Price To Sales | 6.98 X | ||||
| Revenue | 3.09 M | ||||
| Gross Profit | (74.02 M) |
Omega Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Omega Therapeutics's current stock value. Our valuation model uses many indicators to compare Omega Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Omega Therapeutics competition to find correlations between indicators driving Omega Therapeutics's intrinsic value. More Info.Omega Therapeutics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Omega Therapeutics' Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Omega Therapeutics' earnings, one of the primary drivers of an investment's value.Omega Therapeutics Systematic Risk
Omega Therapeutics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Omega Therapeutics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Omega Therapeutics correlated with the market. If Beta is less than 0 Omega Therapeutics generally moves in the opposite direction as compared to the market. If Omega Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Omega Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Omega Therapeutics is generally in the same direction as the market. If Beta > 1 Omega Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Omega Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Omega Therapeutics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Omega Therapeutics growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Omega Therapeutics November 29, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Omega Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Omega Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Omega Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Omega Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Omega Therapeutics's daily price indicators and compare them against related drivers.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 47.73 | |||
| Value At Risk | (8.66) | |||
| Potential Upside | 8.86 |
Complementary Tools for Omega Stock analysis
When running Omega Therapeutics' price analysis, check to measure Omega Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omega Therapeutics is operating at the current time. Most of Omega Therapeutics' value examination focuses on studying past and present price action to predict the probability of Omega Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Omega Therapeutics' price. Additionally, you may evaluate how the addition of Omega Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Stocks Directory Find actively traded stocks across global markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |